Abstract ID: 26-536
Botulinum toxin type A in scar modulation after direct brow lift
Author: Renata Lemos Base Hospital / Institution: University of São Paulo (USP)
Presentation Type: Rapid Fire Presentation Session: Ptosis & MiscellaneousDate: 12th SeptemberTime: 10.18AM
Purpose
To evaluate the effect of botulinum toxin type A (BTX-A) on scar quality following direct brow lift using an intraindividual comparison with saline solution after six months of follow-up.
Methods
This randomized, controlled, double-blind, intraindividual clinical trial included patients who received BTX-A on one side and an equivalent volume of 0.9% saline solution on the contralateral side between postoperative days 3 and 7. BTX-A (abobotulinumtoxinA, Dysport®, 500 U vial diluted in 3.5 mL saline) was injected exclusively along the scar length at a dose of 7.5 U every 2 cm. Scar quality at 180 days was assessed using the Patient and Observer Scar Assessment Scale (POSAS), Vancouver Scar Scale (VSS), Stony Brook Scar Evaluation Scale (SBSES), and Visual Analogue Scale (VAS). Statistical analysis was performed using linear mixed-effects models with patient-level random intercepts. The study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee.
Results
Fifty-two patients were enrolled, and 46 completed follow-up and were included in the final analysis. Significant improvement in scar quality was observed on the BTX-A-treated side in the POSAS (β = -0.97; 95% CI: -1.36 to -0.58; p < 0.001), VSS (β = -0.50; 95% CI: -0.71 to -0.29; p < 0.001), and VAS (β = -0.43; 95% CI: -0.57 to -0.29; p < 0.001). In the SBSES, a higher score was observed on the treated side (β = 0.15; 95% CI: 0.00 to 0.30; p = 0.05). Effect sizes were small to moderate, with greater magnitude observed in the VAS and VSS.
Conclusion
Early postoperative BTX-A application following direct brow lift improved scar quality at 180 days, with consistent evidence across multiple assessment scales. The observed effect demonstrated moderate magnitude and clinical relevance, particularly for facial scars.
Additional Authors
| First name | Last name | Base Hospital / Institution |
|---|---|---|
| Juliane | Rodrigues | University of São Paulo (USP) |
| Pandora | Fonseca | Federal University of Campina Grande |
| Carolina | Susanna | University of São Paulo (USP) |
| Janaína | Brabo | University of São Paulo (USP) |
| Rogério | Leal | University of São Paulo (USP) |
| Ivana | Pereira | University of São Paulo (USP) |
| Suzana | Matayoshi | University of São Paulo (USP) |
